MDBH MDB CAPITAL HOLDINGS LLC

PatentVest and Docana Announce Strategic Partnership to Accelerate IP Strategy and AI Innovation

PatentVest and Docana Announce Strategic Partnership to Accelerate IP Strategy and AI Innovation

Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- PatentVest, Inc., a leader in intellectual property strategy and prosecution, announces a strategic partnership with Docana, Inc., an emerging innovator in AI-powered enterprise knowledge extraction. This collaboration represents a shared commitment to advancing scalable innovation through the integration of robust IP frameworks and cutting-edge artificial intelligence.

As part of the partnership, PatentVest will provide strategic legal and IP consulting services to support the growth and protection of Docana’s technology portfolio. In return, Docana will grant PatentVest access to its next-generation AI platform, designed to streamline document analysis, automate reasoning, and accelerate enterprise decision-making.

Unlocking Value Through Complementary Capabilities

“Partnering with PatentVest gives us access to deep expertise in intellectual property that’s essential as we scale. Their strategic insight will ensure that our innovations in enterprise AI are protected and positioned for long-term success.” — Docana, Inc.

With decades of experience supporting innovation-driven companies across emerging technology sectors, PatentVest will help Docana develop a layered and future-ready intellectual property strategy—including patent protection, trade secrets management, and competitive positioning.

At the same time, Docana’s AI platform will enhance PatentVest’s internal knowledge workflows, offering a real-world example of how artificial intelligence can transform the delivery of IP strategy services.

“Docana represents the next wave of enterprise AI, and we’re thrilled to support their journey with strategic IP guidance. This partnership also gives us a unique opportunity to shape how AI can elevate the way IP strategy is built and delivered.” — Javier Chamorro, COO, PatentVest

About PatentVest

PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is the first integrated IP intelligence, strategy, and law firm designed to help visionary companies become technology leaders. By combining a proprietary database with a proven diligence process and expert analysis, PatentVest delivers actionable insights that help clients navigate complex IP landscapes and stay ahead of the curve. This report is powered by PatentVest’s proprietary IP intelligence platform.

About Docana

Docana is a deep tech company leveraging proprietary artificial intelligence to automate enterprise document intelligence and unlock knowledge at scale. Its platform combines natural language processing and workflow automation to accelerate complex decision-making in data-intensive environments.

For more information or inquiries, please contact .



EN
27/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MDB CAPITAL HOLDINGS LLC

 PRESS RELEASE

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Le...

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter Management to Host Conference Call Today at 4:30 p.m. ET Addison, TX, March 31, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining disruptive technology companies, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025. More Detailed Information 2025 Annual Shareholder Letter . Form 10-K . Key Assets and Strategic Developments eXoZymes (NASDAQ: EXOZ): MDB holds appr...

 PRESS RELEASE

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Ra...

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine.” The report provides a comprehensive analysis of the rapidly evolving amylin drug landscape, a mechanism once considered commercially unviable that is now at the center of global pharmaceutical strategy. Over the past eighteen months, more than $19 billion i...

 PRESS RELEASE

PatentVest Highlights New Legal Article on AI Patenting Strategy by Se...

PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspectives on intellectual property strategy, emerging technology, and innovation-driven industries. The IP Legal Insights section serves as a resource for founders, executives, and investors seeking to better understand how intellectual property decisions impact innovation, competitive positioning...

 PRESS RELEASE

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stak...

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stake in Exchange for IP Intelligence Services IP Strategy and Legal firm backs vascular technology innovator with both expertise and capital commitment Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest, a leading provider of IP Strategy and Legal services, today announced a strategic engagement with Life Seal Vascular and disclosed that it has accepted equity in the company as partial consideration for its services. The arrangement reflects PatentVest's conviction in Life Seal Vascular's underlying technology and...

 PRESS RELEASE

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results...

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time Addison, TX, March 23, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founde...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch